Beam Therapeutics announced positive initial data for BEAM-302 in the Phase I/II trial in Alpha-1 Antitrypsin Deficiency (AATD).
16 小时
Zacks Investment Research on MSNBEAM Down Despite Positive Initial Data From Genetic Disorder StudyBeam Therapeutics Inc. BEAM announced positive initial safety and efficacy data from a phase I/II study, which is evaluating ...
MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a common, contagious virus affecting the lungs and breathing ...
The decision by Chief Justice Geoffrey Morawetz was announced March 6, and it means eligible Canadians can register to get ...
Lung diseases are no joke. Whether it’s something as common as asthma or as serious as lung cancer, the health of our lungs ...
On March 11, 2020, the World Health Organization declared the 2019 Novel Coronavirus to be a pandemic. Within days, the ...
Dec. 25, 2024 — A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果